Skull Base and Nonskull Base Chordomas: Clinicopathologic and Immunohistochemical Study with Special Reference to Nuclear Pleomorphism and Proliferative Ability

Cancer

Volumn 98, Issue 9, 2003, Pages 1934-1941

  Naka, Takahiko ^a   Boltze, Carsten ^a   Samii, Amir ^b   Herold, Christian ^b   Ostertag, Helmut ^b   Iwamoto, Yukihide ^c   Oda, Yoshinao ^c   Tsuneyoshi, Masazumi ^c   Kuester, Doerthe ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Hanover Hospital   (Germany)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Chordoma; MIB 1; Pleomorphism; Prognosis; Proliferative ability; Recurrence

Indexed keywords

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BONE TUMOR; CANCER GRADING; CELL PROLIFERATION; CHILD; CHORDOMA; FEMALE; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NOTOCHORD; PRIORITY JOURNAL; PROGNOSIS; SKULL BASE CHORDOMA; SKULL BASE TUMOR; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; APOPTOSIS; BONE NEOPLASMS; CELL DIVISION; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CHORDOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; SKULL BASE NEOPLASMS; SURVIVAL RATE;

EID: 0142212234     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11756     Document Type: Article

References (28)

1. Rich TA, Schiller A, Suit HE, Mankin HJ. Clinical and pathologic review of 48 cases of chordoma. Cancer. 1985;56:182-187.
2. Chambers PW, Schwinn CP. Chordoma: a clinicopathologic study of metastasis. Am J Clin Pathol. 1979;72:765-776.
3. Eriksson B, Gunterberg B, Kindblom LG. Chordoma: a clinicopathologic and prognostic study of a Swedish National Series. Acta Orthop Scand. 1981;52:49-58.
4. Murad TM, Murthy MSN. Ultrastructure of a chordoma. Cancer. 1970;25:1204-1215.
5. O'Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzerider JE, Rosenberg A. Base of skull chordoma: a correlative study of histologic and clinical features of 62 cases. Cancer. 1994;74:2261-2267.
6. Naka T, Fukuda T, Chuman H, et al. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum Pathol. 1996;27:381-388.
7. Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32:410-420.
8. Rosenberg AE, Brown GA, Bhan AK, Lee JM. Chondroid chordoma- a variant of chordoma: a morphologic and immunohistochemical study. Am J Clin Pathol. 1994;101:36-41.
9. Matsuno A, Sasaki T, Nagashima T, et al. Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas. Hum Pathol. 1997;28:714-719.
10. Bergh P, Kindblom L, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122-2134.
11. Holton J, Steel T, Luxsuwong M, Crockard H, Revesz T. Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index. Neuropathol Appl Neurobiol. 2000;26:497-503.
12. Paavolainen P, Teppo L. Chordoma in Finland. Acta Orthop Scand. 1976;47:46-51.
13. Schoedel K, Martinez A, Mahoney T, Contis L, Becich M. Chordomas: pathological features; ploidy and silver nucleolar organizing region analysis: a study of 36 cases. Acta Neuropathol (Berl). 1995;89:139-143.
14. Bottles K, Beckstead JH. Enzyme histochemical characterization of chordomas. Am J Surg Pathol. 1984;8:443-447.
15. Mirra J. Chordoma. In: Mirra J, editor. Bone tumors. Philadelphia: Lea & Febiger, 1989:648-674.
16. Volpe R, Mazabraud A. A clinicopathologic review of 25 cases of chordoma: a pleomorphic and metastasizing neoplasm. Am J Surg Pathol. 1983;7:161-170.
17. Horn K, Fowler J, Carrau R, Barnes E, Rao U. Cytokeratin immunophenotyping of an unusual cervical vertebral chordoma with extensive chondroid foci and perilaryngeal recurrence: a case report with review of the literature. Am J Otolaryngol. 2001;22:428-434.
18. Kawai T, Suzuki M, Kono S, et al. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma: correlation with DNA flow cytometric analysis. Cancer. 1994;74:2468-2475.
19. Brinck U, Stachura J, Kellner S, Schauer A. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histiocytoma. Anticancer Res. 1995;15:1915-1919.
20. Sadun F, Hinton D, Sadun A. Rapid growth of anoptic nerve ganglioglioma in a patient with neurofibromatosis 1. Ophthalmology. 1996;103:794-799.
21. Mikami T, Terada T, Nakamura K, Okayasu I. The gastric hypercellular microleiomyoma as a precursor lesion for clinical gastrointestinal stromal tumors. Hum Pathol. 1997;28:1355-1360.
22. Abe M, Kawase T, Urano M, et al. Analyses of proliferative potential in schwannomas. Brain Tumor Pathol. 2000;17:35-40.
23. Zehr R, Bauer T, Marks K, Weltevreden A. Ki-67 and grading of malignant fibrous histiocytomas. Cancer. 1990;66:1984-1990.
24. Vilovic K, Sapunar D, Ilijic E, Mimica M, England M, Saraga-Babic M. Morphological characteristics of dying cells in axial structures of developing embryos. Cells Tissues Organs. 2001;169:347-354.
25. Kay S, Schatzki P. Ultrastructural observations of a chordoma arising in the clivus. Hum Pathol. 1972;3:403-413.
26. Harvey W, Dawson E. Chordoma. Edinb Med J 1941;48:713-730.
27. Forsyth PA, Cascino TL, Shaw EG, et al. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg. 1993;78:741-747.
28. Colli B, Al-Mefty O. Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg. 2001;95:933-943.